Arbovirus Testing Market
Arbovirus Testing Market Analysis by ELISA-based Tests and RT-PCR Tests Done at Hospitals, Public Health Laboratories, and Diagnostic Centers from 2024 to 2034
Analysis of Arbovirus Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Arbovirus Testing Market Outlook (2024 to 2034)
The global arbovirus testing market size is estimated at US$ 1.43 billion in 2024, according to a new Fact.MR market study. Worldwide demand for arbovirus testing is predicted to increase at a 5.7% CAGR and reach a market value of US$ 2.49 billion by the end of 2034.
The increasing prevalence of arboviral diseases, including Zika, West Nile virus, chikungunya, and dengue, among people is predicted to stimulate the demand for efficient and accurate testing methods. Constant advancements are taking place in diagnostic technologies, including ELISA (enzyme-linked immunosorbent assay), PCR (polymerase chain reaction), rapid testing kits, and nucleic acid amplification, which are contributing to more specific, sensitive, and rapid testing for arboviruses.
Funding for research, government initiatives, and public health campaigns are predicted to aim to control and prevent the spread of arbovirus diseases, which is projected to positively impact the adoption of testing technologies. Rising travel is predicted to contribute to the growing spread of arboviral infections among people across geographies, which is leading to increased demand for test kits.
Increasing awareness among the general public and healthcare professionals related to the symptoms, preventive measures, and risks associated with arboviral infections are set to propel the requirement for testing, prevention, and diagnosis.
Constant product innovations by prominent players for the development of more affordable, user-friendly, and accurate diagnostic tools are predicted to contribute to arbovirus testing market growth opportunities.
- Revenue from arbovirus testing solutions in public health laboratories is forecasted to advance at a CAGR of 5.8% and reach US$ 897.4 million by the end of 2034.
- Demand for arbovirus testing in China is predicted to increase at 6.5% CAGR and reach a value of US$ 176.8 million by 2034-end.
- Public health laboratories are projected to account for 36.1% share of global market revenue by 2034.
Several stringent guidelines and regulations by health authorities about the safety, quality, and efficacy of arbovirus diagnostic tools are predicted to positively impact market dynamics and growth.
| Report Attributes | Details |
|---|---|
| Arbovirus Testing Market Size (2024E) | US$ 1.43 Billion |
| Forecasted Market Value (2034F) | US$ 2.49 Billion |
| Global Market Growth Rate (2024 to 2034) | 5.7% CAGR |
| North America Market Share(2034F) | 18.1% |
| Demand Growth in Japan (2024 to 2034) | 5.2% CAGR |
| United States Market Value (2034F) | US$ 286 Million |
| Arbovirus Testing in Public Health Laboratories Segment Value (2024E) | US$ 897.4 Million |
| ELISA-based Test Segment Share (2034F) | 59.2% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Contributing to the Expanding Arbovirus Testing Market Size?
“Rising Cases of Arboviral Infections Prompting More Research Efforts across the World”
There has been an unprecedented increase in the cases of arboviral diseases over the past few years. Conventionally, these diseases are associated with certain climates or regions. These cases are also found in new geographical areas owing to several factors, including increased travel, climate change, etc.
Dengue was once confined to subtropical and tropical regions, currently, its cases are also found in other regions as well. Arbovirus infections pose challenges to public health owing to their potential to cause epidemics and outbreaks. Several diseases, including Zika, dengue, and chikungunya, are expected to lead to severe symptoms, including rashes, neurological complications, joint pain, high fever, and even fatalities.
Rising cases of arbovirus infections are predicted to spur research efforts for a better understanding of the epidemiology, pathogenesis, and transmission dynamics of these diseases. These R&D activities are anticipated to contribute to the development of more effective and better diagnostic tools, along with creating awareness about their surveillance, prevention, and control.
“Government Initiatives and Funding Stimulating Adoption of Testing Technologies”
Most governments recognize arbovirus diseases as a pivotal health concern owing to their potential to cause public health emergencies, severe illness, and outbreaks. Consequently, more governments generally prioritize these healthcare issues in their health agendas, providing funding, allocating resources, and establishing programs, aimed at surveillance, control, and prevention.
More governments are entering into collaboration with research institutions and public health agencies to provide funding for R&D activities related to arbovirus infection. They aim to support scientific investigations into several aspects of arboviral diseases, including pathogenesis, vaccine development, diagnostics, and epidemiology. Financial support and research grants facilitate the development of novel testing technologies, protocols, and tools for the diagnosis of arboviral infections rapidly and accurately.
What Can Adversely Impact Arbovirus Testing Market Growth?
“Lack of Awareness and Limited Access to Diagnostic Testing Techniques”
There is a lack of awareness about the facilities available for arbovirus infections among people in developing countries. In addition, limited access to these advanced diagnostic procedures in developing countries is predicted to reduce their adoption.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Start-ups Establishing Themselves in This Competitive Market?
“Focus on Exploration of Innovative Testing Methodologies”
There is always room for innovations in testing methodologies. The development of more economical, rapid, and accurate diagnostic tools against arbovirus infections is predicted to widen the scope for new entrants. Some of the advancements include point-of-testing, molecular diagnostics, and novel platforms, which can enhance specificity and sensitivity.
Country-wise Insights
As per fact.MR report, North America is projected to hold 18.1% share of global market revenue by 2034. This is attributed to the increased adoption of several technologically advanced products and increased healthcare expenditure.
Why is the United States a Key Market for Arbovirus Testing Solutions?
“Availability of Sophisticated Diagnostic Tests in the Country”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 190.9 Million |
| Growth Rate (2024 to 2034) | 4.1% CAGR |
| Projected Value (2034F) | US$ 286 Million |
The United States is predicted to hold a 63.4% share of the North American market by 2034. The market in the United States is predicted to hold a significant share of the regional market because of the rising prevalence of arbovirus infection. In addition, the growing availability of point-of-care molecular diagnostics in clinical facilities is also widening their application scope. Moreover, the presence of a well-established healthcare infrastructure and increased healthcare spending are also predicted to positively impact market growth opportunities.
The rising population of elderly people, who are susceptible to viral infections, is also predicted to accelerate demand for testing facilities. Furthermore, the development of integrated response strategies to reduce arbovirus cases is also contributing to revenue streams.
How Fast is Demand for Arbovirus Testing Rising in China?
“Larger Population Density Leading to More Cases of Arboviral Infections”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 94.2 Million |
| Growth Rate (2024 to 2034) | 6.5% CAGR |
| Projected Value (2034F) | US$ 176.8 Million |
China is forecasted to account for 46.7% share of the East Asia market by 2034. The larger population in China is predicted to lead to a wider spread of arboviral diseases. Therefore, requirements for effective testing solutions are experienced by patients and healthcare providers, which are predicted to widen the scope for players there.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
According to the study published by Fact.MR, a market research and competitive intelligence provider, public health laboratories are predicted to adopt arbovirus testing services extensively to promote knowledge sharing, improve testing accuracy, and standardize testing protocols.
Why is There Higher Adoption of ELISA-based Tests?
“Easy Availability and Accessibility of ELISA-based Tests”
| Attribute | ELISA-based Tests |
|---|---|
| Segment Value (2024E) | US$ 850.4 Million |
| Growth Rate (2024 to 2034) | 5.6% CAGR |
| Projected Value (2034F) | US$ 1.47 Billion |
ELISA-based tests are projected to hold a 59.2% share of global market revenue by 2034. ELISA-based tests are used for the assessment of the effectiveness of control measures, guiding targeted interventions, and identifying areas with higher risks that are forecasted to contribute to segment growth. In addition, the easy accessibility and accuracy of ELISA-based tests are attracting arbovirus testing market trends.
Increased demand for ELISA-based tests is also attributed to a growing focus on R&D activities along with technological advancements to detect arbovirus disorders. Several innovations along with constant improvements in assay sensitivity, design, and specificity for improved diagnostic effectiveness and pocket-friendly prices, are predicted to offer noteworthy growth potential.
Which End User Accounts for Widespread Use of Arbovirus Testing Solutions?
“Extensive Adoption of Arbovirus Testing by Public Health Laboratories”
| Attribute | Public Health Laboratories |
|---|---|
| Segment Value (2024E) | US$ 510.8 Million |
| Growth Rate (2024 to 2034) | 5.8% CAGR |
| Projected Value (2034F) | US$ 897.4 Million |
Public health laboratories are projected to hold 36.1% arbovirus testing market share by 2034. An increasing number of public health laboratories is predicted to lead to extensive adoption of several advanced diagnostic techniques for arbovirus testing, including high-throughput platforms and rapid molecular assays to enable more accurate and faster arbovirus detection.
Several public health laboratories are entering into collaborations with public health agencies, diagnostic companies, and research institutions to expand their facilities in testing services. In addition, they also promote standardization of testing protocols and knowledge sharing and invest in novel technology development, which is predicted to lead to improved efficiency and accuracy in testing procedures.
Competitive Landscape
Prominent suppliers of arbovirus testing tools are adopting several strategies to achieve set purposes, including management of supply chain systems, ensuring quality control of products, and innovations. Companies are implementing several growth strategies, including product launches and collaborations, to gain a competitive edge.
For instance :
- Mylab, in July 2022, launched the PathoDetect Extended Monsoon Fever Panel. This newly developed RT-PCR test kit works more effectively for monsoon disorders, including dengue, malaria, and Zika. This newly developed kit offers accurate results in two hours along with a mass testing feature.
Key players in the arbovirus testing industry are Agilent Technologies Inc., NovaTec Immundiagnostica GmbH, Thermo Fisher Scientific, Euroeimmun AG, Abbot Laboratories, Bio-Rad, DiaSorin SpA, Fluke Biomedical, Distek, Copley Scientific, Becton, Distek, Dickinson and Company, Hoffmann La Roche Ltd., Merck kGaA F, QIAGEN N.V., and Siemens Healthineers AG.
Segmentation of Arbovirus Testing Market Research
-
By Test Type :
- ELISA-based Tests
- RT-PCR Tests
-
By End User :
- Hospitals
- Public Health Laboratories
- Diagnostic Centers
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Test Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Test Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Test Type launches 5.2.2. Cost of Test Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Test Type 6.4.2. Revenue By End User 6.4.3. Revenue By Country 6.5. 2023 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034 7.1. Historical Market Volume (Units) Analysis, 2018 to 2023 7.2. Current and Future Market Volume (Units) Projections, 2024 to 2034 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Test Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034 9.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 9.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Test Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2018 to 2023 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2024 to 2034 10.3.1. ELISA-based Tests 10.3.2. RT-PCR Tests 10.4. Market Attractiveness Analysis By Test Type 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2018 to 2023 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024 to 2034 11.3.1. Hospitals 11.3.2. Public Health Laboratories 11.3.3. Diagnostic Centers 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 to 2023 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Test Type 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Test Type 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Test Type 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Test Type 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Test Type 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Test Type 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Test Type 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Test Type 20.2.2. By End User 20.3. Canada Market Analysis 20.3.1. By Test Type 20.3.2. By End User 20.4. Mexico Market Analysis 20.4.1. By Test Type 20.4.2. By End User 20.5. Brazil Market Analysis 20.5.1. By Test Type 20.5.2. By End User 20.6. U.K. Market Analysis 20.6.1. By Test Type 20.6.2. By End User 20.7. Germany Market Analysis 20.7.1. By Test Type 20.7.2. By End User 20.8. France Market Analysis 20.8.1. By Test Type 20.8.2. By End User 20.9. Italy Market Analysis 20.9.1. By Test Type 20.9.2. By End User 20.10. Spain Market Analysis 20.10.1. By Test Type 20.10.2. By End User 20.11. BENELUX Market Analysis 20.11.1. By Test Type 20.11.2. By End User 20.12. Russia Market Analysis 20.12.1. By Test Type 20.12.2. By End User 20.13. China Market Analysis 20.13.1. By Test Type 20.13.2. By End User 20.14. Japan Market Analysis 20.14.1. By Test Type 20.14.2. By End User 20.15. South Korea Market Analysis 20.15.1. By Test Type 20.15.2. By End User 20.16. India Market Analysis 20.16.1. By Test Type 20.16.2. By End User 20.17. ASEAN Market Analysis 20.17.1. By Test Type 20.17.2. By End User 20.18. Australia Market Analysis 20.18.1. By Test Type 20.18.2. By End User 20.19. New Zealand Market Analysis 20.19.1. By Test Type 20.19.2. By End User 20.20. GCC Countries Market Analysis 20.20.1. By Test Type 20.20.2. By End User 20.21. Turkey Market Analysis 20.21.1. By Test Type 20.21.2. By End User 20.22. South Africa Market Analysis 20.22.1. By Test Type 20.22.2. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Test Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Agilent Technologies Inc. 22.3.1.1. Overview 22.3.1.2. Test Type Portfolio 22.3.1.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. NovaTec Immundiagnostica GmbH 22.3.2.1. Overview 22.3.2.2. Test Type Portfolio 22.3.2.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Thermo Fisher Scientific 22.3.3.1. Overview 22.3.3.2. Test Type Portfolio 22.3.3.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Euroeimmun AG 22.3.4.1. Overview 22.3.4.2. Test Type Portfolio 22.3.4.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Abbot Laboratories 22.3.5.1. Overview 22.3.5.2. Test Type Portfolio 22.3.5.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Bio-Rad 22.3.6.1. Overview 22.3.6.2. Test Type Portfolio 22.3.6.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. DiaSorin SpA 22.3.7.1. Overview 22.3.7.2. Test Type Portfolio 22.3.7.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Fluke Biomedical 22.3.8.1. Overview 22.3.8.2. Test Type Portfolio 22.3.8.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Distek 22.3.9.1. Overview 22.3.9.2. Test Type Portfolio 22.3.9.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Copley Scientific 22.3.10.1. Overview 22.3.10.2. Test Type Portfolio 22.3.10.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Becton 22.3.11.1. Overview 22.3.11.2. Test Type Portfolio 22.3.11.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Distek 22.3.12.1. Overview 22.3.12.2. Test Type Portfolio 22.3.12.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. Dickinson and Company 22.3.13.1. Overview 22.3.13.2. Test Type Portfolio 22.3.13.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.14. Hoffmann La Roche Ltd. 22.3.14.1. Overview 22.3.14.2. Test Type Portfolio 22.3.14.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 22.3.15. Merck kGaA F 22.3.15.1. Overview 22.3.15.2. Test Type Portfolio 22.3.15.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.15.4. Sales Footprint 22.3.15.5. Strategy Overview 22.3.16. QIAGEN N.V. 22.3.16.1. Overview 22.3.16.2. Test Type Portfolio 22.3.16.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.16.4. Sales Footprint 22.3.16.5. Strategy Overview 22.3.17. Siemens Healthineers AG 22.3.17.1. Overview 22.3.17.2. Test Type Portfolio 22.3.17.3. Profitability by Market Segments (Test Type/Channel/Region) 22.3.17.4. Sales Footprint 22.3.17.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Test Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Test Type, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Test Type, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Test Type, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Test Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By End User, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Test Type, 2024 (E)
Figure 18: North America Market Value Share, By End User, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Test Type, 2024 (E)
Figure 26: Latin America Market Value Share, By End User, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Test Type, 2024 (E)
Figure 34: Europe Market Value Share, By End User, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Test Type, 2024 (E)
Figure 42: South Asia Market Value Share, By End User, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Test Type, 2024 (E)
Figure 50: East Asia Market Value Share, By End User, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Test Type, 2024 (E)
Figure 58: Oceania Market Value Share, By End User, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Test Type, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Test Type, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By End User, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Test Type, 2024 (E)
Figure 78: Canada Market Value Share, By End User, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Test Type, 2024 (E)
Figure 81: Mexico Market Value Share, By End User, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Test Type, 2024 (E)
Figure 84: Brazil Market Value Share, By End User, 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Test Type, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By End User, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Test Type, 2024 (E)
Figure 90: Germany Market Value Share, By End User, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Test Type, 2024 (E)
Figure 93: France Market Value Share, By End User, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Test Type, 2024 (E)
Figure 96: Italy Market Value Share, By End User, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Test Type, 2024 (E)
Figure 99: Spain Market Value Share, By End User, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Test Type, 2024 (E)
Figure 102: Russia Market Value Share, By End User, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Test Type, 2024 (E)
Figure 105: China Market Value Share, By End User, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Test Type, 2024 (E)
Figure 108: Japan Market Value Share, By End User, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Test Type, 2024 (E)
Figure 111: South Korea Market Value Share, By End User, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Test Type, 2024 (E)
Figure 114: India Market Value Share, By End User, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Test Type, 2024 (E)
Figure 117: ASEAN Market Value Share, By End User, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Test Type, 2024 (E)
Figure 120: Australia Market Value Share, By End User, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Test Type, 2024 (E)
Figure 123: New Zealand Market Value Share, By End User, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Test Type, 2024 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Test Type, 2024 (E)
Figure 129: Turkey Market Value Share, By End User, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Test Type, 2024 (E)
Figure 132: South Africa Market Value Share, By End User, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the arbovirus testing market in 2024?
The global arbovirus testing market is pegged at US$ 1.43 billion in 2024.
What is the demand projection for arbovirus testing?
Demand for arbovirus testing solutions is forecasted to increase at 5.7% CAGR from 2024 to 2034.
What valuation is the global market anticipated to reach by 2034?
The market for arbovirus testing is forecasted to reach US$ 2.49 billion by the end of 2034.
What is the projected contribution of the North American region to the global market?
North America is projected to hold 18.1% share of global market revenue by 2034.
At what rate is the demand for arbovirus testing projected to increase in Japan?
Demand for arbovirus testing in Japan is predicted to increase at a CAGR of 5.2% from 2024 to 2034.
Which laboratory test is widely employed for the detection of arbovirus?
Molecular and serological testing is widely used for arbovirus detection.
Arbovirus Testing Market